Cornerstone Therapeutics Inc. (NASDAQ:CRTX)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

Recs

1
Player Avatar romad829 (33.81) Submitted: 8/15/2007 8:47:14 PM : Outperform Start Price: $2.46 CRTX Score: +105.40

Will go up post fall season.

Featured Broker Partners


Advertisement